Monday, October 5, 2026

Selling Cenovus: Up 78% in 10 Months

Cenovus Energy, up 78% in 10 months, is sold after agreeing to buy Athabasca Oil for $5.7 billion at a rich valuation.

CVE $61B

Bison Insights Oct 5 4 clicks

Oct 5 GFL $16B

The Final Countdown: An Update on GFL’s Sale

310 Value’s Newsletter

Oct 5 CRWV $34B

The Thin Margin of Safety in Selling Compute

MBI Deep Dives 11 clicks

From X

@stockgutter Aug 11 1 click

SG on X

Me, I bought this crap (around $21.4). $SMCI https://t.co/yRsywgjrZw

@majgeoinvesting Aug 11

Maj Soueidan on X

Can’t say there’s any slam dunk information arbitrage out of @InfoArbMonitor last batch of Delta Sheets, but there’s still a few interesting tid bits. $ASYS and $PAYS are not crazy cheap, but could be on future numbers. $NNBR probably has the best momentum, but they just went through some massive dilution. $ASYS might be my favorite out of the bunch. Thinking about buying it back at some point.

@ChrisCamillo Aug 11 1 click

Chris Camillo on X

@eager28 No I’m invested indirectly via $SKM

@HaydenCapital Aug 11 1 click

Fred Liu on X

I think $MELI's up for same reason $SE's up. Signs that Sea's reinvestment cycle is turning (or least not as aggressive as feared - see the 2H ebitda guide), which means less pressure on MELI. And maybe MELI margins have found a bottom / will inflect soon too. + Just maybe, both can co-exist & grow 50% y/y.

@TheBenSchmark Aug 11 1 click

JabroniCoin.USD on X

For FY 2027, the Company expects net sales in the range of $65.0 billion to $72.0 billion. Net sales in the range of $14.5 billion & $15.5 billion for the first quarter of FY 2027 ending September, 2026, and non-GAAP net income per diluted share of $1.01 to $1.10 $SMCI 👀 https://t.co/BMrEvmCbQj

@majgeoinvesting Aug 11

Maj Soueidan on X

Just finished going over the $BWEN Q2 earnings script. There might be a glimmer of hope it to keep it interesting in the short term: •Unfortunately, 19% EBITDA industrial segment margins will “fall to more normal levels.” For the last three years, that’s ranged between 11 and 15%. However, revenue will be above historical levels. •Backlog is exceptionally strong, with visibility out to 2028. These guys have never had that kind of visibility. •It looks like a chance for profitability comes from me two scenarios. 1). Aggressively growing the industrial segment because it doesn’t look like margin expansion will occur. 2). The gearing segment EBITDA margins have been historically low, under 10%. So an expansion there, while also getting revenue growth might be interesting. •As far as acquisitions go, I’m not holding out for them finding a great deal. You have to think that valuations will be extended. I would actually prefer them to take their time, by being patient and growing organically - filling some of the available capacity they have right now. •In the end, it’s all about margins for these guys. They really have had a hard time keeping them stable.

@Mike10947310 Aug 11 1 click

Mike on X

@kingtutcap I know $VELO well any others to look at? Maybe something involved in missile production?

@irbezek Aug 11 1 click

Ian Bezek on X

@shortbus_ace @akeemcap @QuietProsperity $CAAP is 6x EV/EBITDA and no Mexico. But half of EBITDA is from Argentina, so that's its own can of worms (albeit the Argy fees are charged at a fixed USD rate not Peso)

Portfolio Update September 2026

Portfolio added Otis Worldwide in the mid-$60s, increased Pool, Copart and Floor & Decor, and sold Berkshire Hathaway.

OTIS $26BCPRT $26B

D Invests Oct 5 1 click

Brazil could be the Q4 Macro Play – My stock ideas: $NU, $INTR, $PICS and maybe $STNE, $PAGS, $DLO and $MELI

Brazilian fintechs NU, INTR and PICS stand to benefit from a Bolsonaro-led runoff surprise that lowers fiscal risk premiums, rates and the…

NU $75BINTR $3B

Substack von Philipp Oct 5 6 clicks

Nyxoah: Label Expansion Set To Unlock A Monopoly In A Billion Dollar Market.

Nyxoah's Genio implant could reach CCC patients after an FDA label expansion, targeting 30% of the obstructive sleep apnea device market by…

NYXH $112M

Stephen Tobin Oct 5 3 clicks

OMSE 2026-10-05

The Monday Morning Briefing: AI Drives Everything, Yet ROI on Massive Capex Remains Uncertain

Latticework’s briefing questions AI capex returns while featuring Close Brothers, Green Landscaping and OMS Energy Technologies.

OMSE $177M

Latticework by MOI Global Oct 5 2 clicks

Geely: Strategic NIO Battery Deal Is A Win

Geely’s ZEEKR nearly doubled first-half 2026 deliveries to 178,000, while Geely bought 30% of NIO’s battery-swapping unit to reduce…

NIO $8.7B

The Asian Investor Oct 4 5 clicks

Practical Parametric Yield

Cerebras’s WSE-3 faces parametric-yield constraints that could restrict supply, making power and clock-speed tradeoffs central to its next…

CBRS $33B

Irrational Analysis Oct 4 3 clicks

Did Group 1 Overpay for Hennessy? The Seller’s Own Banker Says It Was a Record.

Group 1 paid $1 billion of goodwill for Hennessy’s 10 dealerships, a record $100 million per store, financed largely with $1.25 billion of…

GPI $2.9B

Cannibal Stocks Oct 4 4 clicks

M&T: Buy Reaffirmed, Despite Market Pullback, As Growth And Earnings Story Remain Strong

M&T Bank's 10.4% five-year revenue CAGR, improving net interest margin and commercial loan growth support its earnings resilience despite a…

MTB $31B

Albert Anthony Oct 3 2 clicks

EVI Industries. Margin inflection or fake out?

EVI Industries says its ERP and service-platform build is largely complete, testing whether 10.8% revenue growth can finally outpace…

EVI $243M

Kairos Research Oct 2 2 clicks

EXCLUSIVE: Lennar’s Big New Customer Is Its Own Spinoff, Millrose

Lennar is selling homes to former spinoff Millrose, whose revenue largely comes from Lennar and whose largest voting shareholder is…

LEN $17BMRP $3.7B

Hunterbrook Oct 2 2 clicks

HRVFF · long

Harvia Oyj

HRVFF $937M

Value Investors Club Jul 7 2 clicks

Pyxis Oncology: Better Runway Is Bullish For MICVO's Remaining R&D

Pyxis Oncology's recent financing extends MICVO's runway to clinical milestones as the oncology candidate works to establish a safe,…

PYXS $150M

Myriam Alvarez Oct 4 2 clicks

Single Stock Spotlight #16: Huckleberry.AI (HUCK)

Huckleberry.AI trades near $3.30 against $221 million of cash and $900 million-plus of NOLs after selling its operating business, creating…

HUCK $147M

Hidden Rock Capital's Newsletter Oct 2 5 clicks

Nike: The Defense Holds, the Offense Is Unproven

Nike targets EBIT margin recovery from 5.2% in FY2027 to 13% by FY2032 as revenue declines persist and wholesale, China and digital remain…

NKE $52B

Latticework by MOI Global Oct 2 3 clicks

Nike, Part Two: The Deep Dive

Nike’s second Latticework program examines the company and the global athletic footwear and apparel industry for professional investors.

NKE $52B

Latticework by MOI Global Oct 2 1 click

Nike, Part One: The Story

Nike grew from a $1,000 shoe-distribution venture in 1964 into the largest sports brand, using athlete endorsements, product innovation and…

NKE $52B

Latticework by MOI Global Oct 2 2 clicks

Boeing F/A-XX Win: A Surprise Blow For Northrop

Boeing won the $20 billion Navy F/A-XX contract after securing the Air Force F-47, concentrating U.S.

NOC $68B

Dhierin Bechai Oct 2

Rocket Lab (NASDAQ: RKLB) Stock Rating: Accumulate After Q2 FY12/26 Earnings

Rocket Lab reported Q2 revenue up 62% to $234.1 million and backlog up 137% to $2.36 billion, while operating losses and cash burn…

RKLB $35BIRDM $4.9B

Cestrian Capital Research Oct 2

Research & Analysis | AAR Corp. (NYSE: AIR): MRO Holdings Reshapes the Margin Profile

AAR’s $1.8 billion acquisition of a 65% stake in MRO Holdings adds widebody aircraft maintenance and targets a 19% to 20% EBITDA margin by…

AIR $3.9B

Monte Independent Investment Research Oct 2 4 clicks

American Healthcare REIT: A Dip Buy Driven By Senior-Care And Outpatient Tailwind

American Healthcare REIT’s senior-housing and outpatient portfolio is driving FFO growth and dividend safety, while a rich valuation limits…

AHR $12B

Albert Anthony Oct 2 1 click

SG on X

Maj Soueidan on X

Chris Camillo on X

Fred Liu on X

JabroniCoin.USD on X

Maj Soueidan on X

Mike on X

Ian Bezek on X

Investor Letters

Publications we follow

Newsletters 107

YouTube 4

Blogs 17

Seeking Alpha 52 of 236

X accounts we follow

Investor letters we follow

Sectors